Lung Cancer
Volume 68, Issue 1 , Pages 84-88, April 2010

Phase I trial of carboplatin/paclitaxel/bortezomib and concurrent radiotherapy followed by surgical resection in Stage III non-small cell lung cancer☆

University of Maryland Greenebaum Cancer Center, 22 S. Greene Street, Baltimore, MD 21201, United States of America

Received 27 February 2009; received in revised form 7 May 2009; accepted 11 May 2009. published online 22 June 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Supported by a grant from Millenium Pharmaceuticals.

PII: S0169-5002(09)00267-0

doi:10.1016/j.lungcan.2009.05.003

Lung Cancer
Volume 68, Issue 1 , Pages 84-88, April 2010

Article Tools